RNAC vs DYOR
Comparison between Cartesian Therapeutics Inc (RNAC, Company) and Insight Digital Partners II (DYOR, Company).
RNAC is from the Healthcare sector, while DYOR is from the Financial Services sector.
RNAC vs DYOR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
RNAC vs DYOR - Historical Returns
Returns include dividend reinvestment.
RNAC vs DYOR - Annual Returns (2016 - 2026)
Returns include dividend reinvestment.
| Year | RNAC | DYOR |
|---|---|---|
| 2026 | +17.16% | +1.61% |
| 2025 | -57.41% | -0.50% |
| 2024 | -8.88% | N/A |
| 2023 | -40.05% | N/A |
| 2022 | -65.86% | N/A |
| 2021 | +9.03% | N/A |
| 2020 | +31.74% | N/A |
| 2019 | -17.93% | N/A |
| 2018 | -74.02% | N/A |
| 2017 | -43.23% | N/A |
| 2016 | +22.50% | N/A |
RNAC vs DYOR Drawdown Comparison
The maximum drawdown for RNAC was -99.26%, occurring on Jun 5, 2026. This drawdown has not yet recovered.
The maximum drawdown for DYOR was -0.60%, occurring on Nov 26, 2025. Recovery took 50 trading sessions.
The current RNAC drawdown is -99.00%. The current DYOR drawdown is -0.30%.
| Rank | RNAC | DYOR |
|---|---|---|
| #1 | -99.26% Nov 25, 2016 - Jun 5, 2026 | -0.60% Nov 18, 2025 - Feb 2, 2026 |
| #2 | -24.79% Jul 13, 2016 - Sep 21, 2016 | -0.59% Jun 5, 2026 - Jun 30, 2026 |
| #3 | -16.26% Sep 26, 2016 - Oct 18, 2016 | -0.40% Feb 2, 2026 - Apr 20, 2026 |
| #4 | -7.33% Nov 11, 2016 - Nov 22, 2016 | -0.30% May 15, 2026 - May 28, 2026 |
| #5 | -5.47% Oct 19, 2016 - Oct 31, 2016 | -0.20% May 4, 2026 - May 11, 2026 |
| #6 | -2.75% Nov 8, 2016 - Nov 10, 2016 | -0.20% May 11, 2026 - May 15, 2026 |
| #7 | -2.49% Sep 21, 2016 - Sep 23, 2016 | -0.10% May 28, 2026 - Jun 5, 2026 |
| #8 | -1.35% Nov 3, 2016 - Nov 7, 2016 | -0.05% Apr 30, 2026 - May 4, 2026 |
| #9 | -0.36% Jul 8, 2016 - Jul 13, 2016 | N/A |
| #10 | -0.29% Jun 23, 2016 - Jul 8, 2016 | N/A |
Correlation
Correlation between RNAC and DYOR is 0.42 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks